BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1005 related articles for article (PubMed ID: 9262225)

  • 1. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
    Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
    Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
    Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
    Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels.
    Pereira DN; Procianoy RS
    Acta Paediatr; 2003; 92(3):339-45. PubMed ID: 12725550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy.
    Momotani N; Hisaoka T; Noh J; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):738-44. PubMed ID: 1517362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
    Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
    Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of newborns of mothers with Graves' disease.
    Levy-Shraga Y; Tamir-Hostovsky L; Boyko V; Lerner-Geva L; Pinhas-Hamiel O
    Thyroid; 2014 Jun; 24(6):1032-9. PubMed ID: 24472020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central congenital hypothyroidism due to Graves' disease in the mother].
    Liebrand CA; de Mol AC; Kempers MJ; Noordam C
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2229-32. PubMed ID: 17076354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foetal and neonatal thyroid disorders.
    Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
    Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome.
    Hadeed AJ; Asay LD; Klein AH; Fisher DA
    Pediatrics; 1981 Oct; 68(4):494-8. PubMed ID: 6798539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for developmental disorders in infants born to women with Graves disease.
    Mitsuda N; Tamaki H; Amino N; Hosono T; Miyai K; Tanizawa O
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):359-64. PubMed ID: 1379702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated free thyroxine levels detected by a neonatal screening system.
    Tajima T; Jo W; Fujikura K; Fukushi M; Fujieda K
    Pediatr Res; 2009 Sep; 66(3):312-6. PubMed ID: 19542904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM; Khalid BA
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
    Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
    Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy.
    LaFranchi S
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S20-4. PubMed ID: 16707271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
    Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
    Idris I; Srinivasan R; Simm A; Page RC
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):560-5. PubMed ID: 16268809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital thyrotoxicosis in premature infants.
    Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease.
    Kempers MJ; van Trotsenburg AS; van Rijn RR; Smets AM; Smit BJ; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2984-91. PubMed ID: 17504907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.